Pulmonary veno-occlusive disease: a probably underdiagnosed cause of pulmonary hypertension in systemic sclerosis.
Duarte AC, Cordeiro A, Loureiro MJ, Ferreira F.
Clin Rheumatol. 2020 May;39(5):1687-1691. doi: 10.1007/s10067-020-04953-4. Epub 2020 Jan 22.
Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease.
Caron M, Hoa S, Hudson M, Schwartzman K, Steele R.
Eur Respir Rev. 2018 May 15;27(148):170102. doi: 10.1183/16000617.0102-2017. Print 2018 Jun 30.
Acute mediastinitis, mediastinal granuloma, and chronic fibrosing mediastinitis: A review.
Lin J, Jimenez CA.
Semin Diagn Pathol. 2022 Mar;39(2):113-119. doi: 10.1053/j.semdp.2021.06.008. Epub 2021 Jun 15.
Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial.
Khanna D, Lin CJF, Furst DE, Wagner B, Zucchetto M, Raghu G, Martinez FJ, Goldin J, Siegel J, Denton CP.
Am J Respir Crit Care Med. 2022 Mar 15;205(6):674-684. doi: 10.1164/rccm.202103-0714OC.
How Is Pulmonary Function Assessed in Patients With Juvenile Systemic Sclerosis? Do We Have a Good Clinical Standard?
Foeldvari I, Hinrichs B, Torok K, Rosser F, Helmus N.
J Rheumatol. 2023 Sep;50(9):1194-1195. doi: 10.3899/jrheum.2022-0993. Epub 2023 Apr 15.
Pulmonary sclerosis.
JERVELL O.
Acta Med Scand. 1950;138(6):430-6. doi: 10.1111/j.0954-6820.1950.tb10141.x.
Survival in progressive systemic sclerosis with pulmonary involvement: a single-center experience in Istanbul, Turkey.
Zuhur F, Zuhur SS, Zuhur C, Musellim B, Ongen G.
Rheumatol Int. 2012 Jun;32(6):1655-61. doi: 10.1007/s00296-011-1842-x. Epub 2011 Mar 5.
Mediastinal Fibrosis, Pulmonary Vein Stenosis, and the Role of Transesophageal Echocardiography.
Jain A.
J Cardiothorac Vasc Anesth. 2020 Mar;34(3):835-836. doi: 10.1053/j.jvca.2019.10.036. Epub 2019 Oct 25.
[Pulmonary sclerosis].
JULICH H.
Z Arztl Fortbild (Jena). 1954 Jul 1;48(13):437-9.
Tetracyclines and pulmonary inflammation.
Rempe S, Hayden JM, Robbins RA, Hoyt JC.
Endocr Metab Immune Disord Drug Targets. 2007 Dec;7(4):232-6. doi: 10.2174/187153007782794344.
